Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;82(1):381-390.
doi: 10.3233/JAD-210179.

Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at Onset

Jay L P Fieldhouse  1 , Flora T Gossink  2   3 , Thomas C Feenstra  4 , Sterre C M de Boer  1 , Afina W Lemstra  1 , Niels D Prins  1   5 , Femke Bouwman  1 , Ted Koene  1 , Hanneke F M Rhodius-Meester  1   6 , Freek Gillissen  1 , Charlotte E Teunissen  1   7 , Wiesje M van der Flier  1 , Philip Scheltens  1 , Annemieke Dols  2 , Everard G B Vijverberg  1   5 , Yolande A L Pijnenburg  1
Affiliations

Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at Onset

Jay L P Fieldhouse et al. J Alzheimers Dis. 2021.

Abstract

Background: Behavioral variant frontotemporal dementia (bvFTD) is generally considered a young-onset dementia, although age at onset is highly variable. While several studies indicate clinical differences regarding age at onset, no biomarker validated cohort studies with updated clinical criteria have been performed.

Objective: We aimed to examine behavior, cognition, and mortality over the full age spectrum in a cohort of bvFTD patients with neuroimaging, genetic, or histopathological confirmation and exclusion of positive Alzheimer's disease biomarkers or severe cerebrovascular damage.

Methods: In total, 315 patients with a clinical diagnosis of probable or definite bvFTD were included from the Amsterdam Dementia Cohort and grouped into quartiles by age-at-diagnosis. Neuropsychiatric symptoms and cognitive functioning were assessed with the neuropsychiatric inventory, the geriatric depression scale and a neuropsychological test battery. Data on mortality was obtained from the Dutch municipal register. Associations between age-at-diagnosis and clinical features and mortality risk were examined.

Results: Age-at-diagnosis ranged from 26 to 85 years and established quartiles with mean ages of 52±6, 61±2, 66±2, and 74±3 years. In the total sample, 44.4%exceeded an age of 65 years at time of diagnosis. Earlier age-at-diagnosis was associated with more severe behavioral symptoms, while later age-at-diagnosis was associated with more severe memory impairment. Unexpectedly, mortality risk was not associated with age-at-diagnosis.

Conclusion: In bvFTD, symptom profile is associated with age-at-diagnosis. This should be taken into account with regard to diagnostics, patient management, and trial design. Additionally, based on our sample, the prevalence of late-onset bvFTD is higher than generally thought.

Keywords: Behavior; cognition; frontotemporal dementia; late-onset; mortality; young-onset.

PubMed Disclaimer

Conflict of interest statement

Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-0179r1).

Figures

Fig. 1
Fig. 1
Mean scores of neuropsychiatric symptoms per age quartile.
Fig. 2
Fig. 2
Association between memory performance and age-at-diagnosis in bvFTD.
Fig. 3
Fig. 3
Survival in bvFTD, showing Kaplan-Meier curves according to age quartiles; log-rank test is p = 0.155.
See this image and copyright information in PMC

References

    1. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546–1554. - PubMed
    1. Hogan DB, Jetté N, Fiest KM, Roberts JI, Pearson D, Smith EE, Roach P, Kirk A, Pringsheim T, Maxwell CJ (2016) The prevalence and incidence of frontotemporal dementia: A systematic review. Can J Neurol Sci 43, S96–S109. - PubMed
    1. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456–2477. - PMC - PubMed
    1. Neary D, Snowden J, Mann D (2005) Frontotemporal dementia. Lancet Neurol 4, 771–780. - PubMed
    1. Knopman DS, Roberts RO (2011) Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci 45, 330–335. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources